Overview

Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fed Condition

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
A Single-dose, Randomized, two-Period, Cross over Study
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Risperidone